These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 6175286)

  • 41. Pelvic exenteration for advanced malignancy in elderly patients.
    Radwan RW; Evans MD; Davies M; Harris DA; Beynon J;
    Br J Surg; 2016 Jan; 103(2):e115-9. PubMed ID: 26662618
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Clinical evaluation of pelvic exenteration for carcinoma of the lower colon].
    Takeshima H; Ishikawa H; Aikawa A; Kageyama T
    Nihon Hinyokika Gakkai Zasshi; 1984 Jun; 75(6):967-72. PubMed ID: 6503118
    [No Abstract]   [Full Text] [Related]  

  • 43. Total pelvic exenteration for advanced rectal cancer.
    Mukherjee A
    S D J Med; 1999 May; 52(5):153-6. PubMed ID: 10358444
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pelvic exenteration for rectal cancer: a systematic review.
    Yang TX; Morris DL; Chua TC
    Dis Colon Rectum; 2013 Apr; 56(4):519-31. PubMed ID: 23478621
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Determinants of survival following pelvic exenteration for primary rectal cancer.
    Radwan RW; Jones HG; Rawat N; Davies M; Evans MD; Harris DA; Beynon J;
    Br J Surg; 2015 Sep; 102(10):1278-84. PubMed ID: 26095525
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Outcomes of pelvic exenteration for locally advanced primary rectal cancer: Overall survival and quality of life.
    Quyn AJ; Austin KK; Young JM; Badgery-Parker T; Masya LM; Roberts R; Solomon MJ
    Eur J Surg Oncol; 2016 Jun; 42(6):823-8. PubMed ID: 26947962
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Excision of the seminal vesicles for locally advanced and recurrent rectal and sigmoid cancer.
    Keating JP; Manning S; Dennett E; Studd R
    ANZ J Surg; 2017 Sep; 87(9):688-691. PubMed ID: 25827193
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Exenterative surgery for locally advanced rectosigmoid cancers. Is it worthwhile?
    Lopez MJ; Kraybill WG; Downey RS; Johnston WD; Bricker EM
    Surgery; 1987 Oct; 102(4):644-51. PubMed ID: 3660240
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pelvic exenteration.
    Lindsey WF; Wood DK; Briele HA; Greager JA; Walker MJ; Bork J; Das Gupta TK
    J Surg Oncol; 1985 Dec; 30(4):231-4. PubMed ID: 2417058
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Total pelvic exenteration for primary local advanced colorectal cancer.
    Chen HS; Sheen-Chen SM
    World J Surg; 2001 Dec; 25(12):1546-9. PubMed ID: 11775189
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Validation of MRI and Surgical Decision Making to Predict a Complete Resection in Pelvic Exenteration for Recurrent Rectal Cancer.
    Brown WE; Koh CE; Badgery-Parker T; Solomon MJ
    Dis Colon Rectum; 2017 Feb; 60(2):144-151. PubMed ID: 28059910
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Palliative Pelvic Exenteration: Clinical Outcomes and Quality of Life.
    Quyn AJ; Solomon MJ; Lee PM; Badgery-Parker T; Masya LM; Young JM
    Dis Colon Rectum; 2016 Nov; 59(11):1005-1010. PubMed ID: 27749474
    [TBL] [Abstract][Full Text] [Related]  

  • 53. First Report: Robot-Assisted Total Pelvic Exenteration for Locally Advanced Prostate Cancer.
    Castillo OA; Vidal-Mora I; Rodriguez-Carlin A; Silva A; Schatloff O
    J Laparoendosc Adv Surg Tech A; 2015 Jul; 25(7):592-4. PubMed ID: 26134069
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pelvic exenteration for advanced primary and recurrent adenocarcinoma.
    Falk RE; Moffat FL; Makowka L; Konn G; Bulbul MA; Rotstein LE; Bruce AW
    Can J Surg; 1985 Nov; 28(6):539-41. PubMed ID: 2415230
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Outcome for stage II and III rectal and colon cancer equally good after treatment improvement over three decades.
    Fischer J; Hellmich G; Jackisch T; Puffer E; Zimmer J; Bleyl D; Kittner T; Witzigmann H; Stelzner S
    Int J Colorectal Dis; 2015 Jun; 30(6):797-806. PubMed ID: 25922143
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Outcomes and Patterns of Treatment Failure After Surgery for Locally Recurrent Rectal Cancer.
    Harris CA; Solomon MJ; Heriot AG; Sagar PM; Tekkis PP; Dixon L; Pascoe R; Dobbs BR; Frampton CM; Harji DP; Kontovounisios C; Austin KK; Koh CE; Lee PJ; Lynch AC; Warrier SK; Frizelle FA
    Ann Surg; 2016 Aug; 264(2):323-9. PubMed ID: 26692078
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Exenteration as palliation for patients with advanced pelvic malignancy.
    Woodhouse CR; Plail RO; Schlesinger PE; Shepherd JE; Hendry WF; Breach NM
    Br J Urol; 1995 Sep; 76(3):315-20. PubMed ID: 7551839
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transperineal retropubic approach in total pelvic exenteration for advanced and recurrent colorectal and anal cancer involving the penile base: technique and outcomes.
    Mehta AM; Hellawell G; Burling D; Littler S; Antoniou A; Jenkins JT
    Tech Coloproctol; 2018 Sep; 22(9):663-671. PubMed ID: 30306276
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pathology reporting of pelvic exenteration specimens for locally recurrent rectal cancer.
    Däster S; Shin JS; Loizides S; Steffens D; Koh CE; Solomon MJ
    Eur J Surg Oncol; 2021 Aug; 47(8):2100-2107. PubMed ID: 33895021
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Actual role of Hartmann's resection in elective surgical treatment for carcinoma of rectum and sigmoid colon.
    Doci R; Audisio RA; Bozzetti F; Gennari L
    Surg Gynecol Obstet; 1986 Jul; 163(1):49-53. PubMed ID: 3726724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.